Skip to content

Vaginal reconstruction during laparoscopic radical hysterectomy for cervical cancer patients

Usefulness of vaginal reconstruction during laparoscopic radical hysterectomy for cervical cancer patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030210227
Enrollment
10
Registered
2021-08-06
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PS 0-1 uterine cervical cancer, vaginal reconstruction, laparoscopic surgery

Interventions

During laparoscopic uterine malignancies surgery for cervical cancer patients, after vaginal cutting and sample collection, the bladder surface peritoneum and rectal surface peritoneum are sutured to
vaginal reconstruction, cervical cancer, radical hysterectomy

Sponsors

Kisu Iori
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients who strongly desire to maintain sexual function after surgery 2. Histopathological diagnosis of cervical cancer has been obtained. 3. FIGO classification (FIGO2008), advanced stage IA, IB1, IIA1 stage 4. Tumor diameter is 2 cm or less in preoperative evaluation 5. No marked cervical stromal infiltration of the tumor was observed in the preoperative evaluation 6. Preoperative diagnostic imaging shows no lymph node metastasis or distant metastasis 7. ECOG PS 0-1 at the time of consent acquisition 8. The age at the time of obtaining consent is 20 years old or older and 70 years old or younger. 9. The consent of the person has been obtained for participation in this research.

Exclusion criteria

Exclusion criteria: 1. The principal investigator or the investigator has determined that participation in this research is inappropriate. 2. Informed consent can't be obtained. 3. It is judged that there is an extremely high possibility of performing postoperative adjuvant therapy after surgery. 4. Have a mental illness that affects will confirmation

Design outcomes

Primary

MeasureTime frame
Anatomical vaginal length immediately after surgery

Secondary

MeasureTime frame
Vaginal shortening rate and anatomical vaginal length 1 year after surgery Presence / absence / frequency of sexual life Presence or absence of sexual dysfunction 1 year after surgery Incidence of adverse events during surgery Incidence of adverse events during follow-up 1 year after surgery Tumor recurrence rate Presence or absence of postoperative adjuvant therapy

Contacts

Public ContactIori Kisu

Federation of National Public Service Personnel Mutual Aid Associations, Tachikawa Hospital

iori71march@hotmail.co.jp+81-425233131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026